|
|
type i interferon production
|
GO:0032606 |
29 |
0.881
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.788
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.787
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.783
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.763
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.638
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.635
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.608
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.591
|
Human |
|
|
regulation of type i interferon production
|
GO:0032479 |
22 |
0.547
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.533
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
18 |
0.526
|
|
|
|
antigen processing and presentation of peptide antigen via mhc class ii
|
GO:0002495 |
17 |
0.448
|
|
|
|
antigen processing and presentation of exogenous peptide antigen
|
GO:0002478 |
21 |
0.442
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.434
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.427
|
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
26 |
0.421
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.411
|
Human |
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.405
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.386
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.378
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.377
|
Human |
|
|
cytokine production
|
GO:0001816 |
319 |
0.356
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.313
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.306
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.296
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.295
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.282
|
Human |
|
|
activation of immune response
|
GO:0002253 |
138 |
0.267
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.253
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.250
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.246
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.241
|
|
|
|
antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii
|
GO:0002504 |
17 |
0.218
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.216
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.209
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.209
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
30 |
0.206
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.198
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.198
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.189
|
|
|
|
interleukin 12 biosynthetic process
|
GO:0042090 |
8 |
0.183
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.176
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.174
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.173
|
|
|
|
positive regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031666 |
5 |
0.173
|
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class ii
|
GO:0019886 |
14 |
0.171
|
|
|
|
cellular response to nitric oxide
|
GO:0071732 |
4 |
0.171
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.169
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.167
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.165
|
|
|
|
positive regulation of type i interferon production
|
GO:0032481 |
14 |
0.161
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.156
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.155
|
|
|
|
response to nitric oxide
|
GO:0071731 |
4 |
0.147
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.147
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.144
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.135
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.125
|
Human |
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.124
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.123
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.122
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.116
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.115
|
|
|
|
interleukin 6 biosynthetic process
|
GO:0042226 |
12 |
0.111
|
|
|
|
programmed necrotic cell death
|
GO:0097300 |
28 |
0.107
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.106
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.106
|
|
|
|
positive regulation of interleukin 6 production
|
GO:0032755 |
37 |
0.102
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.101
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway
|
GO:0002753 |
10 |
0.101
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.099
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
15 |
0.099
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
25 |
0.096
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.095
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.093
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.093
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.092
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.091
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.089
|
|
|
|
cofactor biosynthetic process
|
GO:0051188 |
41 |
0.085
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.083
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.083
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.082
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.081
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.080
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.077
|
|
|
|
interleukin 1 mediated signaling pathway
|
GO:0070498 |
4 |
0.076
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.075
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.074
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.073
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.073
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.072
|
|
|
|
t helper 1 type immune response
|
GO:0042088 |
25 |
0.070
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.069
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.067
|
|
|
|
myeloid dendritic cell differentiation
|
GO:0043011 |
16 |
0.065
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.064
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.064
|
|
|
|
positive regulation of response to biotic stimulus
|
GO:0002833 |
15 |
0.064
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.064
|
Human |
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.064
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.064
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.063
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.061
|
Human |
|
|
citrate metabolic process
|
GO:0006101 |
3 |
0.061
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.059
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.059
|
|
|
|
regulation of interleukin 6 biosynthetic process
|
GO:0045408 |
11 |
0.058
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.056
|
|
|
|
interferon beta biosynthetic process
|
GO:0045350 |
4 |
0.055
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.054
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.054
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.054
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.053
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.053
|
Human |
|
|
t cell activation
|
GO:0042110 |
289 |
0.052
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.052
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.051
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.051
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.051
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.050
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.050
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.050
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.050
|
|
|
|
tumor necrosis factor mediated signaling pathway
|
GO:0033209 |
13 |
0.048
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.047
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.047
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.047
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.047
|
|
|
|
positive regulation of interleukin 6 biosynthetic process
|
GO:0045410 |
6 |
0.047
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
13 |
0.046
|
Human |
|
|
ossification
|
GO:0001503 |
216 |
0.046
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.046
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.046
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.045
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.045
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.044
|
|
|
|
interferon beta production
|
GO:0032608 |
16 |
0.043
|
Human |
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.043
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.042
|
Human |
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.042
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.042
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.041
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.041
|
|
|
|
interleukin 18 mediated signaling pathway
|
GO:0035655 |
2 |
0.041
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.040
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.040
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.039
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.039
|
|
|
|
regulation of interferon beta biosynthetic process
|
GO:0045357 |
4 |
0.039
|
|
|
|
positive regulation of response to cytokine stimulus
|
GO:0060760 |
11 |
0.039
|
Human |
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.039
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.039
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.039
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.039
|
|
|
|
regulation of interleukin 12 production
|
GO:0032655 |
30 |
0.038
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.038
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.038
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.037
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.037
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.037
|
|
|
|
immunoglobulin secretion
|
GO:0048305 |
17 |
0.037
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.036
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.036
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.035
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.035
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.035
|
Human |
|
|
cell division
|
GO:0051301 |
120 |
0.035
|
|
|
|
cellular response to reactive nitrogen species
|
GO:1902170 |
5 |
0.035
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.034
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.034
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
26 |
0.034
|
|
|
|
cellular response to interleukin 18
|
GO:0071351 |
3 |
0.034
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.033
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.033
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.033
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.032
|
|
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.032
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.032
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.032
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.032
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
42 |
0.031
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.031
|
|
|
|
dendritic cell differentiation
|
GO:0097028 |
26 |
0.031
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.031
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.031
|
|
|
|
toll like receptor 3 signaling pathway
|
GO:0034138 |
4 |
0.030
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.030
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.030
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.030
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.030
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.030
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.029
|
|
|
|
response to interleukin 18
|
GO:0070673 |
4 |
0.029
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.029
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.029
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.028
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.028
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.028
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.027
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.027
|
Human |
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.027
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.027
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.027
|
Human |
|
|
myd88 independent toll like receptor signaling pathway
|
GO:0002756 |
3 |
0.027
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.027
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.027
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.027
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.026
|
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
27 |
0.026
|
|
|
|
hatching
|
GO:0035188 |
4 |
0.026
|
|
|
|
positive regulation of b cell proliferation
|
GO:0030890 |
24 |
0.026
|
|
|
|
response to molecule of fungal origin
|
GO:0002238 |
4 |
0.026
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.026
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.026
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.025
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.025
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.024
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.024
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.024
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.024
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.024
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.024
|
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
29 |
0.024
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.024
|
|
|
|
regulation of interleukin 12 biosynthetic process
|
GO:0045075 |
8 |
0.024
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.023
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.023
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.023
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.023
|
|
|
|
rna stabilization
|
GO:0043489 |
9 |
0.023
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.023
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.023
|
|
|
|
response to interleukin 1
|
GO:0070555 |
11 |
0.023
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.023
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.023
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.022
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.022
|
|
|
|
thioester metabolic process
|
GO:0035383 |
19 |
0.022
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.022
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.022
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.022
|
|
|
|
response to dsrna
|
GO:0043331 |
30 |
0.022
|
Human |
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.022
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.022
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.022
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.022
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.022
|
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
25 |
0.022
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.021
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
21 |
0.021
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.021
|
|
|
|
coenzyme biosynthetic process
|
GO:0009108 |
23 |
0.021
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.021
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.021
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.021
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.021
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.021
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.021
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.021
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.020
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.020
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.020
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.020
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.020
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.020
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.020
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.020
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.020
|
|
|
|
type i interferon biosynthetic process
|
GO:0045351 |
9 |
0.020
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.020
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.020
|
Human |
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.020
|
Human |
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.020
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.020
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.019
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.019
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.019
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.019
|
|
|
|
regulation of interleukin 18 production
|
GO:0032661 |
3 |
0.019
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.019
|
|
|
|
interleukin 12 production
|
GO:0032615 |
32 |
0.019
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.019
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.019
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.019
|
|
|
|
translation
|
GO:0006412 |
93 |
0.019
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.019
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.018
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.018
|
|
|
|
macrophage activation
|
GO:0042116 |
27 |
0.018
|
|
|
|
regulation of antibacterial peptide biosynthetic process
|
GO:0002808 |
1 |
0.018
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.018
|
|
|
|
positive regulation of interferon beta biosynthetic process
|
GO:0045359 |
3 |
0.018
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.018
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.018
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.018
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.018
|
|
|
|
regulation of lipopolysaccharide mediated signaling pathway
|
GO:0031664 |
9 |
0.018
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.018
|
Human |
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.017
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.017
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.017
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.017
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.017
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.017
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.017
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.017
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.017
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.017
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.017
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.017
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.017
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.017
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.017
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.017
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.017
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.017
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.017
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.017
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.017
|
|
|
|
positive regulation of interferon beta production
|
GO:0032728 |
8 |
0.016
|
Human |
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.016
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.016
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.016
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.016
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.016
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.016
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.016
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.016
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.016
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.016
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.016
|
|
|
|
toll like receptor 9 signaling pathway
|
GO:0034162 |
6 |
0.016
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.015
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.015
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.015
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.015
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.015
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.015
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.015
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.015
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.015
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.015
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.015
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.015
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.015
|
Human |
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.015
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.015
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.015
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.015
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.015
|
|
|
|
positive regulation of chemokine biosynthetic process
|
GO:0045080 |
6 |
0.015
|
|
|
|
tricarboxylic acid metabolic process
|
GO:0072350 |
5 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.014
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.014
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.014
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.014
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
11 |
0.014
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.014
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.014
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.014
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.014
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.014
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.014
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.014
|
|
|
|
acyl coa metabolic process
|
GO:0006637 |
19 |
0.014
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.014
|
|
|
|
mrna stabilization
|
GO:0048255 |
9 |
0.014
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.014
|
|
|
|
positive regulation of antimicrobial humoral response
|
GO:0002760 |
2 |
0.014
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.014
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.014
|
|
|
|
positive regulation of antibacterial peptide biosynthetic process
|
GO:0006963 |
1 |
0.013
|
|
|
|
pigment biosynthetic process
|
GO:0046148 |
26 |
0.013
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.013
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.013
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.013
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.013
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.013
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.013
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.013
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.013
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.013
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
30 |
0.013
|
Human |
|
|
glycosylation
|
GO:0070085 |
62 |
0.013
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.013
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.013
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.013
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.013
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.013
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.013
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.013
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.013
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.013
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.013
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.013
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.013
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.013
|
Human |
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.013
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.013
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.013
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.013
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.013
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.013
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.012
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.012
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.012
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.012
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.012
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.012
|
|
|
|
t cell anergy
|
GO:0002870 |
4 |
0.012
|
|
|
|
regulation of response to cytokine stimulus
|
GO:0060759 |
23 |
0.012
|
Human |
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.012
|
|
|
|
positive regulation of chemokine production
|
GO:0032722 |
22 |
0.012
|
Human |
|
|
rig i signaling pathway
|
GO:0039529 |
4 |
0.012
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.012
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.012
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.012
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.012
|
|
|
|
protein k63 linked ubiquitination
|
GO:0070534 |
6 |
0.012
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.012
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.012
|
|
|
|
ribonucleoside bisphosphate metabolic process
|
GO:0033875 |
9 |
0.012
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.012
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.012
|
|
|
|
regulation of antimicrobial peptide production
|
GO:0002784 |
1 |
0.012
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.012
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.012
|
Human |
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
|
regulation of antibacterial peptide production
|
GO:0002786 |
1 |
0.012
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.011
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.011
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.011
|
|
|
|
positive regulation of interleukin 12 biosynthetic process
|
GO:0045084 |
6 |
0.011
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.011
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.011
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.011
|
|
|
|
retrograde vesicle mediated transport golgi to er
|
GO:0006890 |
1 |
0.011
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.011
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.011
|
|
|
|
amp metabolic process
|
GO:0046033 |
4 |
0.011
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.011
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.011
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.011
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.011
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.011
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.011
|
|
|
|
regulation of chemokine biosynthetic process
|
GO:0045073 |
8 |
0.011
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.011
|
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.011
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.011
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.011
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.011
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.011
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.011
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
|
chemokine metabolic process
|
GO:0050755 |
10 |
0.011
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.011
|
|
|
|
positive regulation of myelination
|
GO:0031643 |
5 |
0.011
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.011
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.011
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.011
|
|
|
|
positive regulation of interleukin 17 production
|
GO:0032740 |
3 |
0.011
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.011
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.011
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.011
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.011
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.011
|
|
|
|
regulation of defense response to fungus
|
GO:1900150 |
1 |
0.011
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.011
|
|
|
|
response to copper ion
|
GO:0046688 |
3 |
0.011
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.011
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.011
|
|
|
|
porphyrin containing compound biosynthetic process
|
GO:0006779 |
16 |
0.011
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.011
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.011
|
Human |
|
|
cellular response to interleukin 1
|
GO:0071347 |
8 |
0.011
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.011
|
|